• Explore /
  • Poster
  • / Subgroup analysis in patients (pts) with non-squamous (N-Sq), EGFR-wild type (wt), second/third-line NSCLC from the global phase (Ph) 3 trial DUBLIN-3 (BPI-2358-103) with the plinabulin/docetaxel (Plin/Doc) combination versus Doc alone.

Subgroup analysis in patients (pts) with non-squamous (N-Sq), EGFR-wild type (wt), second/third-line NSCLC from the global phase (Ph) 3 trial DUBLIN-3 (BPI-2358-103) with the plinabulin/docetaxel (Plin/Doc) combination versus Doc alone.

Abstract Poster

Authors

Baohui Han

Baohui Han

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

Baohui Han , Trevor Feinstein , Yuankai Shi , Michael Chen , Lan Huang , Ramon W. Mohanlal , Yan Sun

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02504489

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9090)

DOI

10.1200/JCO.2022.40.16_suppl.9090

Abstract #

9090

Poster Bd #

77

Abstract Disclosures

Similar Posters

First Author: Trevor Feinstein

First Author: Jin-Ji Yang

First Author: Benjamin Besse

First Author: D. Ross Camidge